| Catalog | Description | Size | Price (USD) | Qty |
|---|---|---|---|---|
| GBM-1142-10MG | P32/98 | 10mg | $210.00 | |
| GBM-1142-50MG | P32/98 | 50mg | $840.00 |
| Bioassays Specification | |
| Bio-Activity | DPPIV inhibitor |
| Chemical Name | (2S,3S)-2-Amino-3-methyl-1-(thiazolidin-3-yl)pentan-1-one hemi-fumarate |
| Function / Pharmacology | A potent and selective inhibitor of dipeptidyl peptidase IV (DPPIV) (Ki=130 nM). May be used in cell cuture (1-10 M) or in vivo (10 mg/kg orally). Cell permeable. Experimental anti-diabetic agent. This product not approved for human therapeutic use. |
| CAS# | 136259-20-6 |
| MW | 202.32 ∙ 58.04 |
| Molecular Formula | C9H18N2OS • 1/2(C4H4O4) |
| Solubility | Soluble in DMSO (up to 25 mg/ml) or in Water (up to 20 mg/ml). |
| Supplied | powder |
| Storage as supplied | -20°C |
| Ship temp | Ambient |
| Antibody Specification | |
| Alternate Names | Isoleucine thiazolidide hemi-fumarate |
| Protein Specification | |
| Purity | >98% |
| Bioassays Specification | |
| Bio-Activity | DPPIV inhibitor |
| Chemical Name | (2S,3S)-2-Amino-3-methyl-1-(thiazolidin-3-yl)pentan-1-one hemi-fumarate |
| Function / Pharmacology | A potent and selective inhibitor of dipeptidyl peptidase IV (DPPIV) (Ki=130 nM). May be used in cell cuture (1-10 M) or in vivo (10 mg/kg orally). Cell permeable. Experimental anti-diabetic agent. This product not approved for human therapeutic use. |
| CAS# | 136259-20-6 |
| MW | 202.32 ∙ 58.04 |
| Molecular Formula | C9H18N2OS • 1/2(C4H4O4) |
| Solubility | Soluble in DMSO (up to 25 mg/ml) or in Water (up to 20 mg/ml). |
| Supplied | powder |
| Storage as supplied | -20°C |
| Ship temp | Ambient |
| Antibody Specification | |
| Alternate Names | Isoleucine thiazolidide hemi-fumarate |
| Protein Specification | |
| Purity | >98% |
